Keisuke Taki

477 total citations
10 papers, 127 citations indexed

About

Keisuke Taki is a scholar working on Infectious Diseases, Molecular Medicine and Applied Microbiology and Biotechnology. According to data from OpenAlex, Keisuke Taki has authored 10 papers receiving a total of 127 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Molecular Medicine and 3 papers in Applied Microbiology and Biotechnology. Recurrent topics in Keisuke Taki's work include Antibiotic Use and Resistance (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Keisuke Taki is often cited by papers focused on Antibiotic Use and Resistance (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Keisuke Taki collaborates with scholars based in Japan. Keisuke Taki's co-authors include Tatsuya Fukumoto, Mutsumi Nishida, Junichi Sugita, Sumio Iwasaki, Kasumi Hayasaka, Takanori Teshima, Satoshi Oguri, Satoshi Konno, Shinichi Fujisawa and Sho Nakakubo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Infection and Immunity and International Journal of Infectious Diseases.

In The Last Decade

Keisuke Taki

9 papers receiving 114 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keisuke Taki Japan 4 57 35 35 18 17 10 127
Kelly Conde‐Pérez Spain 8 56 1.0× 61 1.7× 27 0.8× 14 0.8× 6 0.4× 14 182
Alice J. Fraser United Kingdom 6 64 1.1× 28 0.8× 26 0.7× 6 0.3× 4 0.2× 8 157
Matthew Davies United Kingdom 8 28 0.5× 56 1.6× 10 0.3× 8 0.4× 16 0.9× 11 122
Christine M. Toutain-Kidd United States 8 23 0.4× 90 2.6× 16 0.5× 15 0.8× 12 0.7× 10 311
Monique Melo Costa France 10 42 0.7× 48 1.4× 23 0.7× 3 0.2× 2 0.1× 16 210
Green Kim South Korea 9 79 1.4× 79 2.3× 5 0.1× 47 2.6× 40 2.4× 23 241
Dr. Md. Shahidul Islam Bangladesh 4 65 1.1× 29 0.8× 18 0.5× 54 3.0× 36 2.1× 8 150
Xiangyang Ge China 9 129 2.3× 54 1.5× 5 0.1× 4 0.2× 20 1.2× 22 166
S.L. Hefle United States 8 11 0.2× 74 2.1× 8 0.2× 59 3.3× 11 0.6× 12 434
Oliver Carnell United Kingdom 7 90 1.6× 78 2.2× 17 0.5× 15 0.8× 7 0.4× 9 163

Countries citing papers authored by Keisuke Taki

Since Specialization
Citations

This map shows the geographic impact of Keisuke Taki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Taki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Taki more than expected).

Fields of papers citing papers by Keisuke Taki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Taki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Taki. The network helps show where Keisuke Taki may publish in the future.

Co-authorship network of co-authors of Keisuke Taki

This figure shows the co-authorship network connecting the top 25 collaborators of Keisuke Taki. A scholar is included among the top collaborators of Keisuke Taki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keisuke Taki. Keisuke Taki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Iwasaki, Sumio, Kasumi Hayasaka, Tatsuya Fukumoto, et al.. (2023). Breaking away from an endemic state of multidrug-resistant Pseudomonas aeruginosa by daily sink disinfection. SHILAP Revista de lepidopterología. 3(1). e209–e209.
3.
Ishiguro, Nobuhisa, Takehiro Yamada, Sumio Iwasaki, et al.. (2021). Clinical outcomes of intervention for carbapenems and anti-methicillin-resistant Staphylococcus aureus antibiotics by an antimicrobial stewardship team. American Journal of Infection Control. 49(12). 1493–1498. 4 indexed citations
4.
Ishiguro, Nobuhisa, Takehiro Yamada, Sumio Iwasaki, et al.. (2020). Efficacy and safety of colistin for the treatment of infections caused by multidrug-resistant gram-negative bacilli. Journal of Infection and Chemotherapy. 27(3). 473–479. 3 indexed citations
5.
Taki, Keisuke, Isao Yokota, Tatsuya Fukumoto, et al.. (2020). SARS-CoV-2 detection by fluorescence loop-mediated isothermal amplification with and without RNA extraction. Journal of Infection and Chemotherapy. 27(2). 410–412. 25 indexed citations
6.
Fukumoto, Tatsuya, Sumio Iwasaki, Shinichi Fujisawa, et al.. (2020). Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification. International Journal of Infectious Diseases. 98. 16–17. 33 indexed citations
7.
Taki, Keisuke, Takanori Watanabe, Junji Matsuo, et al.. (2018). Impact of bacterial traces belonging to the Enterobacteriaceae on the prevalence of Chlamydia trachomatis in women visiting a community hospital in Japan. Journal of Infection and Chemotherapy. 24(10). 815–821. 2 indexed citations
8.
Shiraishi, Minoru, et al.. (2001). Sports Injury in J-league Players. 21(3). 277. 1 indexed citations
9.
Endo, Satoshi, K Inada, Yoshihiro Yamada, et al.. (1990). Evaluation of IPM/CS in gram-negative bacillus infections: use of an endotoxin-specific assay.. PubMed. 12(4). 352–6. 2 indexed citations
10.
Taki, Keisuke, et al.. (1981). Effect of oral administration of lysozyme or digested bacterial cell walls on immunostimulation in guinea pigs. Infection and Immunity. 31(2). 580–583. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026